These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3874706)

  • 21. Role of self carriers in the immune response and tolerance. VI. Induction and reversal of TNP-modified self unresponsiveness in vitro.
    Li JT; Scott DW
    J Immunol; 1980 Dec; 125(6):2380-4. PubMed ID: 6968782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hapten-specific unresponsiveness in mice. III. Study of the B-cell functions of tolerant mice.
    Huchet R; Grandjon D
    Scand J Immunol; 1985 Apr; 21(4):337-43. PubMed ID: 2408325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carrier-directed anti-hapten responses by B-cell subsets.
    Lewis GK; Goodman JW
    J Exp Med; 1977 Jul; 146(1):1-10. PubMed ID: 68986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP.
    Marcinkiewicz J; Chain B
    Immunology; 1989 Oct; 68(2):185-9. PubMed ID: 2530159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective expansion of H-2 restricted cytotoxic T lymphocytes to TNP-self by injection of trinitrobenzene sulfonate.
    Shearer GM; Levy RB
    Ann N Y Acad Sci; 1982; 392():137-43. PubMed ID: 6814322
    [No Abstract]   [Full Text] [Related]  

  • 26. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-surface antigenic modifications with trinitrophenyl sulfonate versus trifluoromethyl-dinitrophenyl sulfonate.
    Bischoff P; Maugras M; Llorens MC; Oth D
    Immunobiology; 1983 Feb; 164(1):1-12. PubMed ID: 6189780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance induced by TNP-derivatized syngeneic erythrocytes: evidence for cooperation between hapten-specific T and hapten-specific B lymphocytes in the immune response.
    Moody CE; Innes JB; Siskind GW; Weksler ME
    J Immunol; 1978 Mar; 120(3):844-9. PubMed ID: 75928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.
    Forman J; Vitetta ES; Hart DA; Klein J
    J Immunol; 1977 Mar; 118(3):797-802. PubMed ID: 66272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor specificity of Ia-restricted T lymphoblasts activated against trinitrobenzene sulfonate-coupled spleen cells: recognition of distinct trinitrophenyl and Ia moieties.
    Elliott BE; Palfree RG; Mundinger S
    Cell Immunol; 1984 Mar; 84(1):121-37. PubMed ID: 6199119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unresponsiveness in hapten-specific cytotoxic lymphocytes. II. Ability of various TNP-congeners to induce unresponsiveness after repeated treatments beginning at birth.
    Butler LD; Miller SD; Claman HN
    J Immunol; 1982 May; 128(5):1963-7. PubMed ID: 6977577
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of "allogeneic effect"-like reaction by syngeneic TNP-modified lymphoid cells.
    Ptak W; Rewicka M; Marcinkiewicz J
    Immunobiology; 1984 May; 166(4-5):368-81. PubMed ID: 6237045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
    Fujiwara H; Shearer GM
    J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689
    [No Abstract]   [Full Text] [Related]  

  • 35. Intrathymic T cell repertoire after prenatal trinitrobenzene-sulfonic acid-treatment.
    Zöller M
    Cell Immunol; 1990 Mar; 126(1):31-46. PubMed ID: 2302740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression.
    Britz JS; Askenase PW; Ptak W; Steinman RM; Gershon RK
    J Exp Med; 1982 May; 155(5):1344-56. PubMed ID: 6461712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell tolerance: B cells rendered tolerant are present in the immune system in a potentially responsive form.
    Uchiyama T
    Microbiol Immunol; 1980; 24(12):1211-22. PubMed ID: 6971390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance induction during ontogeny. II. Distinct unresponsive states in immature mice question the generality of clonal abortion.
    Waters CA; Diener E
    Eur J Immunol; 1983 Nov; 13(11):928-35. PubMed ID: 6196209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell response.
    Scott CF; Tsurufuji M; Benacerraf B; Sy MS
    J Immunol; 1983 Nov; 131(5):2184-9. PubMed ID: 6195256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus.
    Mond JJ; Scher I; Mosier DE; Baese M; Paul WE
    Eur J Immunol; 1978 Jul; 8(7):459-63. PubMed ID: 99320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.